Squarepoint
MRTX

Squarepoint’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Squarepoint’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,189
Closed -$1.05M – 4155
2023
Q1 		$1.05M Sell
28,189
-4,301
-13% -$193K ﹤0.01% 1861
2022
Q4 		$1.47M Buy
+32,490
New +$2.1M 0.01% 1562
2022
Q3 		– Sell
-72,722
Closed -$4.88M – 3581
2022
Q2 		$4.88M Buy
72,722
+66,382
+1,047% +$4.22M 0.03% 693
2022
Q1 		$521K Buy
+6,340
New +$648K ﹤0.01% 1981
2021
Q4 		– Sell
-1,801
Closed -$319K – 3623
2021
Q3 		$319K Sell
1,801
-8,529
-83% -$1.37M ﹤0.01% 2227
2021
Q2 		$1.67M Buy
+10,330
New +$1.66M 0.01% 1302
2021
Q1 		– Sell
-5,058
Closed -$1.11M – 3754
2020
Q4 		$1.11M Buy
+5,058
New +$1.09M 0.01% 1267
2020
Q1 		– Sell
-10,879
Closed -$1.4M – 2683
2019
Q4 		$1.4M Buy
+10,879
New +$1.05M 0.01% 1123
2019
Q3 		– Sell
-10,100
Closed -$1.04M – 2754
2019
Q2 		$1.04M Sell
10,100
-72,824
-88% -$5.67M 0.01% 1243
2019
Q1 		$6.08M Buy
82,924
+56,545
+214% +$3.85M 0.06% 374
2018
Q4 		$1.12M Buy
+26,379
New +$1.05M 0.01% 880
2018
Q2 		– Sell
-14,200
Closed -$436K – 2126
2018
Q1 		$436K Buy
+14,200
New +$394K 0.01% 1143
2017
Q4 		– Sell
-20,975
Closed -$245K – 2399
2017
Q3 		$245K Buy
+20,975
New +$121K ﹤0.01% 1283

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Squarepoint's MRTX Position: Q2 2023 in Review

Squarepoint sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 28,189 shares — an estimated $1.05M sold.

Squarepoint first reported a position in MRTX in Q3 2017 and held it in 13 quarters. The position peaked at $6.08M in Q1 2019. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

  • Squarepoint reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Squarepoint sold 28,189 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.05M.
  • Squarepoint first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
  • Squarepoint's Mirati Therapeutics, Inc. Common Stock position peaked at $6.08M in Q1 2019.
  • 207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Squarepoint's 13F filing for Q2 2023, filed 14 Aug 2023.